Finance Manager US Oncology - SG&A and Forecasting

About AbbVie AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, oncology and neuroscience - and products and services in our Allergan Aesthetics portfolio. For more information about AbbVie, please visit us at www.abbvie.com . Follow @abbvie on LinkedIn, Facebook , Instagram , X and YouTube.

The Finance Manager, Etenta provides financial planning, reporting, and controllership support for the Etenta commercial team (Multiple Myeloma), and supports the volume and sales forecasting process for the franchise. On the SG&A and controllership side, the position owns SG&A forecasting, monitoring, and reporting — including OPEX and headcount — and progressively assumes ownership of the monthly, quarterly, and annual close, financial-statement accuracy, the internal-control environment (including SOX), and Etenta revenue and sales accounting. On the forecasting side, the position supports the Associate Director, Etenta Volume Forecasting in developing accurate projections of commercial product volumes across the planning cycles — Plan, Update, LBE, LRP, Portfolio, and Actual submissions — and owns the month-end price, volume/demand, and pipeline variance analyses. The role builds and maintains knowledge of the business through close collaboration with cross-functional partners, including Marketing & Sales Management, Market Analytics and Business Insight, Pricing, and Commercial Finance leadership.

A. SG&A & Controllership Own the SG&A forecasting build for Plan, Update, LBE, and LRP — with sound assumptions, clear communication of drivers, and executive-ready deliverables. Own OPEX and headcount management, partnering with business stakeholders to monitor spend against approved budget targets and to flag risks and opportunities through the year. Support, and progressively assume ownership of, the monthly, quarterly, and annual close and reporting for SG&A and revenue, in accordance with GAAP and internal reporting requirements. Maintain the Etenta internal-control environment, including SOX requirements, building toward independent ownership with Finance Director guidance; support the accuracy of the Etenta financial statements. Build and own Etenta SG&A reporting and dashboards to improve transparency of spend across the franchise, with clear and concise variance commentary. Partner with the Etenta commercial team on investment trade-offs and marketing-mix decisions, ensuring launch investments are sufficiently funded and tracked against the approved budget. B. Volume Forecasting Support the Associate Director, Etenta Volume Forecasting in developing accurate product volume and sales projections for Plan, Update, LBE, LRP, Portfolio, and Actual submissions, including market and competitive-landscape inputs. Own the month-end price, volume/demand, and pipeline variance analyses and the associated close commentary, communicating key drivers of performance for the Etenta P&L. Triangulate a wide variety of data sets — market research, competitive events, prescriptions, epidemiology, and market access — to inform forecast assumptions and assess financial impact. Provide ad-hoc analytical support across launch, new-indication, and channel/product-mix scenarios, and represent Etenta finance with Marketing, Market Analytics and Business Insight, and Pricing to keep forecast assumptions aligned to the latest market view.

Required BS/BA in Finance, Accounting, Economics, Business, Analytics, or Mathematics/Statistics. Minimum of five years of progressive experience across FP&A, financial planning, controllership, and/or forecasting. Demonstrated ownership of an SG&A or OPEX